Differences between squamous cell carcinoma and adenocarcinoma of the lung: Are adenocarcinoma and squamous cell carcinoma prognostically equal?

Akikazu Kawase, Junji Yoshida, Genichiro Ishii, Masayuki Nakao, Keiju Aokage, Tomoyuki Hishida, Mitsuyo Nishimura, Kanji Nagai

研究成果: Article

38 引用 (Scopus)

抄録

Objective: We analyzed pulmonary squamous cell carcinoma and adenocarcinoma patient survival in our single institution database, to evaluate the relationship of histologic analysis to survival and tumor aggressiveness. Methods: We reviewed 1856 consecutive patients with surgically resected pulmonary squamous cell carcinoma or adenocarcinoma regarding their clinicopathologic characteristics, overall survival and recurrence-free proportion. Results: In squamous cell carcinoma patients, there were more elderly male smokers and more patients with T2-4 tumors, moderately/poorly differentiated tumors, lymph node metastasis or vascular invasion than in adenocarcinoma patients. In all patients and in pN0 patients, patients with squamous cell carcinoma showed significantly poorer overall survival than those with adenocarcinoma, but there were no statistically significant differences in the recurrence-free proportion between the two histologic types. There were statistically significantly more lung cancer-specific deaths in patients with adenocarcinoma than in patients with squamous cell carcinoma (P= 0.001). Conclusions: There were no differences in the development of recurrence between squamous cell carcinoma and adenocarcinoma of the lung, but considerable differences in overall survival were observed between the two histologic types. According to the stage grouping strategy of the TNM Classification for Lung and Pleural Tumours, these two histologic types need to be staged differently. This survival difference, however, may reflect the difference in patient background rather than in biologic aggressiveness between the two histologic types.

元の言語English
記事番号hyr188
ページ(範囲)189-195
ページ数7
ジャーナルJapanese Journal of Clinical Oncology
42
発行部数3
DOI
出版物ステータスPublished - 2012 3
外部発表Yes

Fingerprint

Squamous Cell Carcinoma
Adenocarcinoma
Survival
Recurrence
Lung
Neoplasms
Adenocarcinoma of lung
Neoplasm Staging
Survival Analysis
Blood Vessels
Lung Neoplasms
Lymph Nodes
Databases
Neoplasm Metastasis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Radiology Nuclear Medicine and imaging

これを引用

Differences between squamous cell carcinoma and adenocarcinoma of the lung : Are adenocarcinoma and squamous cell carcinoma prognostically equal? / Kawase, Akikazu; Yoshida, Junji; Ishii, Genichiro; Nakao, Masayuki; Aokage, Keiju; Hishida, Tomoyuki; Nishimura, Mitsuyo; Nagai, Kanji.

:: Japanese Journal of Clinical Oncology, 巻 42, 番号 3, hyr188, 03.2012, p. 189-195.

研究成果: Article

Kawase, Akikazu ; Yoshida, Junji ; Ishii, Genichiro ; Nakao, Masayuki ; Aokage, Keiju ; Hishida, Tomoyuki ; Nishimura, Mitsuyo ; Nagai, Kanji. / Differences between squamous cell carcinoma and adenocarcinoma of the lung : Are adenocarcinoma and squamous cell carcinoma prognostically equal?. :: Japanese Journal of Clinical Oncology. 2012 ; 巻 42, 番号 3. pp. 189-195.
@article{dad5629f94ae4250a59ca2ba212f3a1f,
title = "Differences between squamous cell carcinoma and adenocarcinoma of the lung: Are adenocarcinoma and squamous cell carcinoma prognostically equal?",
abstract = "Objective: We analyzed pulmonary squamous cell carcinoma and adenocarcinoma patient survival in our single institution database, to evaluate the relationship of histologic analysis to survival and tumor aggressiveness. Methods: We reviewed 1856 consecutive patients with surgically resected pulmonary squamous cell carcinoma or adenocarcinoma regarding their clinicopathologic characteristics, overall survival and recurrence-free proportion. Results: In squamous cell carcinoma patients, there were more elderly male smokers and more patients with T2-4 tumors, moderately/poorly differentiated tumors, lymph node metastasis or vascular invasion than in adenocarcinoma patients. In all patients and in pN0 patients, patients with squamous cell carcinoma showed significantly poorer overall survival than those with adenocarcinoma, but there were no statistically significant differences in the recurrence-free proportion between the two histologic types. There were statistically significantly more lung cancer-specific deaths in patients with adenocarcinoma than in patients with squamous cell carcinoma (P= 0.001). Conclusions: There were no differences in the development of recurrence between squamous cell carcinoma and adenocarcinoma of the lung, but considerable differences in overall survival were observed between the two histologic types. According to the stage grouping strategy of the TNM Classification for Lung and Pleural Tumours, these two histologic types need to be staged differently. This survival difference, however, may reflect the difference in patient background rather than in biologic aggressiveness between the two histologic types.",
keywords = "Adenocarcinoma, Histologic type, Prognosis, Squamous cell carcinoma, TNM classification",
author = "Akikazu Kawase and Junji Yoshida and Genichiro Ishii and Masayuki Nakao and Keiju Aokage and Tomoyuki Hishida and Mitsuyo Nishimura and Kanji Nagai",
year = "2012",
month = "3",
doi = "10.1093/jjco/hyr188",
language = "English",
volume = "42",
pages = "189--195",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Differences between squamous cell carcinoma and adenocarcinoma of the lung

T2 - Are adenocarcinoma and squamous cell carcinoma prognostically equal?

AU - Kawase, Akikazu

AU - Yoshida, Junji

AU - Ishii, Genichiro

AU - Nakao, Masayuki

AU - Aokage, Keiju

AU - Hishida, Tomoyuki

AU - Nishimura, Mitsuyo

AU - Nagai, Kanji

PY - 2012/3

Y1 - 2012/3

N2 - Objective: We analyzed pulmonary squamous cell carcinoma and adenocarcinoma patient survival in our single institution database, to evaluate the relationship of histologic analysis to survival and tumor aggressiveness. Methods: We reviewed 1856 consecutive patients with surgically resected pulmonary squamous cell carcinoma or adenocarcinoma regarding their clinicopathologic characteristics, overall survival and recurrence-free proportion. Results: In squamous cell carcinoma patients, there were more elderly male smokers and more patients with T2-4 tumors, moderately/poorly differentiated tumors, lymph node metastasis or vascular invasion than in adenocarcinoma patients. In all patients and in pN0 patients, patients with squamous cell carcinoma showed significantly poorer overall survival than those with adenocarcinoma, but there were no statistically significant differences in the recurrence-free proportion between the two histologic types. There were statistically significantly more lung cancer-specific deaths in patients with adenocarcinoma than in patients with squamous cell carcinoma (P= 0.001). Conclusions: There were no differences in the development of recurrence between squamous cell carcinoma and adenocarcinoma of the lung, but considerable differences in overall survival were observed between the two histologic types. According to the stage grouping strategy of the TNM Classification for Lung and Pleural Tumours, these two histologic types need to be staged differently. This survival difference, however, may reflect the difference in patient background rather than in biologic aggressiveness between the two histologic types.

AB - Objective: We analyzed pulmonary squamous cell carcinoma and adenocarcinoma patient survival in our single institution database, to evaluate the relationship of histologic analysis to survival and tumor aggressiveness. Methods: We reviewed 1856 consecutive patients with surgically resected pulmonary squamous cell carcinoma or adenocarcinoma regarding their clinicopathologic characteristics, overall survival and recurrence-free proportion. Results: In squamous cell carcinoma patients, there were more elderly male smokers and more patients with T2-4 tumors, moderately/poorly differentiated tumors, lymph node metastasis or vascular invasion than in adenocarcinoma patients. In all patients and in pN0 patients, patients with squamous cell carcinoma showed significantly poorer overall survival than those with adenocarcinoma, but there were no statistically significant differences in the recurrence-free proportion between the two histologic types. There were statistically significantly more lung cancer-specific deaths in patients with adenocarcinoma than in patients with squamous cell carcinoma (P= 0.001). Conclusions: There were no differences in the development of recurrence between squamous cell carcinoma and adenocarcinoma of the lung, but considerable differences in overall survival were observed between the two histologic types. According to the stage grouping strategy of the TNM Classification for Lung and Pleural Tumours, these two histologic types need to be staged differently. This survival difference, however, may reflect the difference in patient background rather than in biologic aggressiveness between the two histologic types.

KW - Adenocarcinoma

KW - Histologic type

KW - Prognosis

KW - Squamous cell carcinoma

KW - TNM classification

UR - http://www.scopus.com/inward/record.url?scp=84857978086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857978086&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyr188

DO - 10.1093/jjco/hyr188

M3 - Article

C2 - 22210923

AN - SCOPUS:84857978086

VL - 42

SP - 189

EP - 195

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 3

M1 - hyr188

ER -